Stock listing

Valerio Therapeutics

Selected listing: ALVIO · EURONEXT · EUR · FR

Valerio Therapeutics (Euronext:ALVIO), Health Technology. Latest release Aug 24, 2026: Valerio Therapeutics Announces Signing of Definitive Agreements…

ALVIO:EURONEXTEURFRUpdated October 3, 2026

Ticker: Euronext:ALVIO
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Euronext
Currency: EUR

About Valerio Therapeutics

Valerio Therapeutics is a public company traded under the ticker ALVIO on the French market. Valerio Therapeutics focuses on developing innovative therapeutic solutions.

Latest news from Valerio Therapeutics

Valerio Therapeutics Announces Signing of Definitive Agreements for the Acquisition of Etherna Immunotherapies, Building a Leading Platform in Targeted RNA, and €40.25 Million PIPE Financing From New and Existing Investors

August 24, 2026

Valerio Therapeutics and Etherna Immunotherapies Progress Towards Finalisation of Transaction Documentation Regarding the Contemplated Acquisition

August 17, 2026

Valerio Therapeutics Announces Development Collaboration with Abivax and Provides Pipeline Update

July 16, 2026

Valerio Therapeutics Announces Binding Offer for the Proposed Acquisition of Etherna Immunotherapies, Creating a Global Leader in Targeted RNA Medicines

July 1, 2026

Valerio Therapeutics : announces binding offer for the proposed acquisition of Etherna Immunotherapies, creating a global leader in targeted RNA medicines

July 1, 2026

All Valerio Therapeutics news →

Research Valerio Therapeutics

Valerio Therapeutics company profile

View the public company page for Valerio Therapeutics on 6ix.

Valerio Therapeutics news

Read company news and market updates connected to Valerio Therapeutics.

Valerio Therapeutics investor events

Find investor webinars, events, and replay context for Valerio Therapeutics.